2022
Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.
The oncologist
•My publications
Filter publications
5 publications
2022
Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review.
The oncologist
•2021
Association of HLA class I homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer treated with chemo-immunotherapy or immunotherapy as first-line therapy.
Heliyon
•2021
Blood transfusions may adversely affect survival outcomes of patients with lung cancer: a systematic review and meta-analysis.
Translational lung cancer research
•2021
Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC).
Cancer immunology, immunotherapy : CII
•